AndreaBozzo/ceres-open-data-index huggingface dataset:
Thrombocytopenia in critically ill surgical patients: a case-control
		  study evaluating attributable mortality and transfusion requirements

Background:
          That thrombocytopenia results in increased mortality or
				transfusion requirements has not been confirmed by previous studies. We
				performed a case-control study in which 36 patients who developed severe
				thrombocytopenia of less than 50×109 platelets/l were carefully
				matched for the severity of underlying disease and other important
				variables.
        
        
          Results:
          Seventeen (47%) thrombocytopenic patients died, versus 10 (28%)
				matched control patients who were not thrombocytopenic.Nine pairs had a
				discordant outcome, and in eight of these pairs the thrombocytopenic patient
				died (exact binomial probability 0.037). The estimated attributable mortality
				was 19.5% (95% confidence interval 3.2⌓35.8), and the estimated odds ratio was
				2.7 (95% confidence interval 1.02⌓7.10). Thrombocytopenic patients had
				comparable values for severity of illness scores between day of admission and
				day of thrombocytopenia, in contrast with control patients who had a
				statistically significant decrease in severity of illness scores during the
				same period. Thirty (83%) of the thrombocytopenic patients required transfusion
				of blood products, versus 21 (58%) control patients (paired χ2
				test 4.92, P < 0.04). The estimated attributable transfusion
				requirement was 25% (95% confidence interval 5.4⌓44.6), and the estimated odds
				ratio was 1.52 (95 confidence interval 1.05⌓2.20).
        
        
          Conclusion:
          The present study suggests that thrombocytopenia of less than
				50 × 109 platelets/l may be a marker for more severe illness and
				increased risk of death, rather than causative, because a true causal
				relationship is not established. Thrombocytopenia also leads to an excess of
				blood product consumption.
CMS Program Statistics - Medicare Total Enrollment

The CMS Program Statistics - Medicare Total Enrollment tables provide data on characteristics of the Medicare-covered populations. 

For additional information on enrollment, providers, and Medicare use and payment, visit the CMS Program Statistics page.

 

Below is the list of tables:


	MDCR ENROLL AB 1.  Total Medicare Enrollment:  Total, Original Medicare, and Medicare Advantage and Other Health Plan Enrollment, Yearly Trend
	MDCR ENROLL AB 2.  Total Medicare Enrollment:  Total, Original Medicare, Medicare Advantage and Other Health Plan Enrollment, and Resident Population, by Area of Residence
	MDCR ENROLL AB 3.  Total Medicare Enrollment:  Part A and/or Part B Total, Aged, and Disabled Enrollees, Yearly Trend
	MDCR ENROLL AB 4.  Total Medicare Enrollment: Part A and/or Part B Enrollees, by Age Group, Yearly Trend
	MDCR ENROLL AB 5.  Total Medicare Enrollment:  Part A and/or Part B Enrollees, by Demographic Characteristics
	MDCR ENROLL AB 6.  Total Medicare Enrollment:  Part A and/or Part B Enrollees, by Type of Entitlement and Demographic Characteristics
	MDCR ENROLL AB 7.  Total Medicare Enrollment:  Part A and/or Part B Total, Aged, and Disabled Enrollees, by Area of Residence
	MDCR ENROLL AB 8.  Total Medicare Enrollment:  Part A and/or Part B Enrollees, by Type of Entitlement and Area of Residence
NSDUH 2019 Sample Experience Report

The goal of this report is to further document the 2019 NSDUH sample experiences, including a comparison of actual sample yields to state and quarter targets, a comparison of achieved and expected design effects (DEFFs) and relative standard errors, and documentation of any issue encountered during sample implementation. The 2019 sample design is thoroughly documented in the 2019 NSDUH sample design report (Center for Behavioral Health Statistics and Quality, 2020).
NNDSS - Table II. Varicella to West Nile virus disease

NNDSS - Table II. Varicella to West Nile virus disease - 2014.In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000 cases but less than or equals 10,000 cases will be displayed (��� 1,000 and ��_ 10,000). The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Case counts for reporting years 2013 and 2014 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. ��� Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNet Surveillance). Data for California serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I. �� Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the Arboviral diseases and influenza-associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/document/SRCA_FINAL_REPORT_2006-2012_final.xlsx.More information on NNDSS is available at http://wwwn.cdc.gov/nndss/.
Compound 526632: (4-Acetyloxy-3-methoxyoxolan-2-yl)methyl acetate

Chemical compound data from PubChem database. IUPAC Name: (4-acetyloxy-3-methoxyoxolan-2-yl)methyl acetate. Molecular Formula: C10H16O6. Molecular Weight: 232.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40137-T1: [Translated] THIENOTHIOPHENE DERIVATIVES.

Thienothiophene derivatives of the formula I R1-(A1)m-Z1-A-(Z2-A2)n-R2 I in which R1 and R2 are each H or an alkyl group having 1-12 C atoms, in which, furthermore, one or two non-adjacent CH2 groups can be replaced by O atoms, -CO- or -CH=CH- groups, or are each F, Cl, Br, CN, -COOR or -O-COR, A1 and A2 are each 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl, pyridazine-3,6-diyl or the corresponding N-oxide, piperidine-1,4-diyl, 1,4-bicyclo[2.2.2]octylene or pyrimidine-2,5-diyl groups which are unsubstituted or substituted by one or two F, Cl or Br atoms and/or CN groups and/or CH3 groups, A is a group of the formula 1 or 2 <IMAGE>   which is unsubstituted or substituted by one or two Cl and/or Br atoms, Z1 and Z2 are each -CO-O-, -O-CO-, -CH2CH2-, -OCH2+13, -CH2O- or a single bond, R is an alkyl group having 1-10 C atoms, m is 1 or 2 and n is 0 or 1, and where m is 2, the two groups A1 can be identical or different, can be used as components of liquid crystalline phases.
Table 18. 2011-2012 NSDUH Illicit Drug Dependence or Abuse in the Past Year, by Age Group and State

Table 18. Illicit Drug Dependence or Abuse in the Past Year, by Age Group and State: Percentages, Annual Averages Based on 2011 and 2012 NSDUHs. Results are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Nursing Home Cost Report (RHCF): 2011

The Nursing Home Cost Report (RHCF) is a uniform report completed by New York nursing homes to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations (Part 86-2.2), nursing homes are required to file financial and statistical data with DOH annually. The data filed is part of the cost report and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends.
Compound 528995: Hexadecane, 2-methyl-1,2-bis(methylthio)

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-1,2-bis(methylsulfanyl)hexadecane. Molecular Formula: C19H40S2. Molecular Weight: 332.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing

Background
          Epidermal homeostasis involves the monitoring of continuous proliferative and differentiative processes as keratinocytes migrate from the basal layer to the skin surface. Recently, differentiation of epidermal stem cells was shown to be promoted by the Notch pathway. This pathway is characterised by cell-cell interactions between transmembrane proteins and was first implicated in lateral inhibition, patterning and cell binary choices during embryogenesis.
        
        
          Methods
          By in situ hybridisation, we investigated the in vivo expression of related genes, namely; Notch 1–3, Delta 1, Jagged 1, Lunatic Fringe, Radical Fringe and Manic Fringe during keratinocyte proliferation and differentiation in humans in basal cell carcinoma, psoriasis and in wound healing experiments, compared with normal adult skin.
        
        
          Results
          We show that the highest level of transcription of these genes is in the basal cell layer of non-lesional skin. Conversely, when keratinocytes were hyperproliferating, as in basal cell carcinoma, psoriasis, and during the first step of re-epithelialisation, expression was weak or non-existent. Furthermore, normal levels of transcripts were rescued in psoriatic plaques when treated by phototherapy, as well as in newly regenerated stratified epidermis following wound healing.
        
        
          Conclusion
          The Notch signalling involved in the differentiation programme of normal adult human epidermis is altered under experimental conditions and pathologies which modify this programme.
Arizona (AZ)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Arizona overall and for substate regions within Arizona. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Compound 528094: tert-Butyldimethylsilyl acetate

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] acetate. Molecular Formula: C8H18O2Si. Molecular Weight: 174.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530460: p-Toluic acid, 4-hexadecyl ester

Chemical compound data from PubChem database. IUPAC Name: hexadecan-4-yl 4-methylbenzoate. Molecular Formula: C24H40O2. Molecular Weight: 360.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526762: 1,3-p-Menthadien-7-al

Chemical compound data from PubChem database. IUPAC Name: 4-propan-2-ylcyclohexa-1,3-diene-1-carbaldehyde. Molecular Formula: C10H14O. Molecular Weight: 150.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528642: 2-Ketopentanoic acid ho-tms

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-trimethylsilyloxyiminopentanoate. Molecular Formula: C11H25NO3Si2. Molecular Weight: 275.49. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Physical mapping of genes in somatic cell radiation hybrids by comparative genomic hybridization to cDNA microarrays

Background
          Somatic cell mutants can be informative in the analysis of a wide variety of cellular processes. The use of map-based positional cloning strategies in somatic cell hybrids to analyze genes responsible for recessive mutant phenotypes is often tedious, however, and remains a major obstacle in somatic cell genetics. To fulfill the need for more efficient gene mapping in somatic cell mutants, we have developed a new DNA microarray comparative genomic hybridization (array-CGH) method that can rapidly and efficiently map the physical location of genes complementing somatic cell mutants to a small candidate genomic region. Here we report experiments that establish the validity and efficacy of the methodology.
        
        
          Results
          CHO cells deficient for hypoxanthine:guanine phosphoribosyl transferase (HPRT) were fused with irradiated normal human fibroblasts and subjected to HAT selection. Cy5-labeled genomic DNA from the surviving hybrids containing the HPRT gene was mixed with Cy3-labeled genomic DNA from normal CHO cells and hybridized to a microarray containing 40,185 cDNAs, representing 29,399 genes (UniGene clusters). The DNA spots with the highest Cy5:Cy3 fluorescence ratios corresponded to a group of genes mapping within a 1 Mb interval centered near position 142.7 Mb on the X chromosome, the genomic location of HPRT.
        
        
          Conclusion
          The results indicate that our physical mapping method based on radiation hybrids and array-CGH should significantly enhance the speed and efficiency of positional cloning in somatic cell genetics.
Abduction paresis with rostral pontine and/or mesencephalic lesions: Pseudoabducens palsy and its relation to the so-called posterior internuclear ophthalmoplegia of Lutz

Background
          The existence of a prenuclear abduction paresis is still debated.
        
        
          Methods
          In a retrospective design, we identified 22 patients with isolated unilateral (n = 20) or bilateral (n = 2) abduction paresis and electrophysiologic abnormalities indicating rostral pontine and/or mesencephalic lesions. Another 11 patients had unilateral abduction paresis with additional ocular motor abnormalities indicating midbrain dysfunction. Eight of these 11 patients also had electrophysiological abnormalities supporting this location. Electrophysiological examinations in all patients included masseter and blink reflexes (MassR, BlinkR), brainstem auditory evoked potentials (BAEP), and direct current elctro-oculography (EOG).
        
        
          Results
          Unilateral MassR abnormalities in patients with unilateral abduction paresis were seen in 17 patients and were almost always (in 16 of 17 patients) on the side of the abduction paresis. Another 11 patients had bilateral MassR abnormalities. BlinkR was always normal. EOG disclosed slowed abduction saccades in the non-paretic eye in 6 patients and slowed saccades to the side opposite to the abduction paresis in another 5 patients. Re-examinations were done in 27 patients showing normalization or improvement of masseter reflex abnormalities in 18 of 20 patients and in all patients with EOG abnormalities. This was always associated with clinical improvement.
        
        
          Conclusions
          Electrophysiologically documented or clinically evident rostral pontine and/or mesencephalic lesions in our patients exclude an infranuclear intrapontine 6th nerve lesion and indicate the existence of an abduction paresis of prenuclear origin. An increased tone of the antagonistic medial rectus muscle during lateral gaze either by abnormal convergence or impaired medial rectus inhibition seems most likely.
Compound 528228: 1-Oxa-4,7-dithionane

Chemical compound data from PubChem database. IUPAC Name: 2-(2-ethylsulfanylethylsulfanyl)ethanol. Molecular Formula: C6H14OS2. Molecular Weight: 166.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401261-T1: [Translated] CHILD-PROOF CARDBOARD PACKAGING

The package has a lamellar blister package arranged in a cuboid-shaped folding box from cardboard and pulled from the box at one of short narrow sides of the folding box. The folding box is recloseably designed, where the folding box and the blister package have strengthening flaps (112, 126), which are arranged in such a manner that complete removal of the blister package from the folding box is prevented.
Patent AT-E400188-T1: [Translated] METHOD FOR THE PRODUCTION OF PROTEIN PREPARATIONS WITH LARGELY CONSTANT PROPERTIES REGARDING SOLUBILITY AND FUNCTIONALITY WITHIN A PH RANGE OF APPROXIMATELY PH 3 TO PH 10

A process for obtaining protein preparations with constant functional properties, comprises extraction from a protein containing raw material, eg leguminous plants, cereals or oil seeds. The raw material undergoes at least one fluid extraction step and the raffinate and/or extract obtained is either fed to a membrane separation process, or subjected to a thermal concentration where a concentrate is obtained. The protein preparation is contained in the retained product or the concentrate.
National Directory of Drug and Alcohol Abuse Treatment Facilities - 1998

The National Directory of Drug and Alcohol Abuse Treatment Programs 199 lists federal, state, local, and private facilities that provide substance abuse treatment services. The directory includes treatment facilities that are licensed, certified, or otherwise approved for inclusion in the directory by their state substance abuse agencies and that responded to the 1997 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this directory was provided by that facility in response to the 1997 N-SSATS. The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-SSATS annually.
Compound 530055: 10,13-Dimethyl-17-(2-methyl-1,3,2-dioxaborolan-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

Chemical compound data from PubChem database. IUPAC Name: 10,13-dimethyl-17-(2-methyl-1,3,2-dioxaborolan-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. Molecular Formula: C22H33BO3. Molecular Weight: 356.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Reduction of exposure to simulated respiratory aerosols using ventilation, physical distancing, and universal masking

The association between human respiratory disease transmission by respiratory droplets and aerosols is well established for several known pathogens.1 Given that the average individual spends > 90% of their day indoors, there has been intense focus on factors associated with indoor transmission. To minimize exposure risks, the Centers for Disease Control and Prevention (CDC) recommends behavioral and personal protective equipment mitigation strategies to limit COVID-19 transmission, including wearing masks, maintaining physical distances of  ≥ 1.8 m, and avoiding crowded indoor and outdoor spaces. As such, the current investigation examines the combined effect of physical distancing, universal masking, and ventilation on exposure to airborne particles generated during breathing and coughing within a controlled indoor environment. The results of this investigation quantitatively examine the contribution of the matrix of controls employed and provides guidance on respiratory disease mitigation strategies within the indoor environment.
Dopaminergic neurons in the brain and dopaminergic innervation of the albumen gland in mated and virgin helisoma duryi (mollusca: pulmonata)

Background
          Dopamine was shown to stimulate the perivitelline fluid secretion by the albumen gland. Even though the albumen gland has been shown to contain catecholaminergic fibers and its innervation has been studied, the type of catecholamines, distribution of fibers and the precise source of this neural innervation has not yet been deduced. This study was designed to address these issues and examine the correlation between dopamine concentration and the sexual status of snails.
        
        
          Results
          Dopaminergic neurons were found in all ganglia except the pleural and right parietal, and their axons in all ganglia and major nerves of the brain. In the albumen gland dopaminergic axons formed a nerve tract in the central region, and a uniform net in other areas. Neuronal cell bodies were present in the vicinity of the axons. Dopamine was a major catecholamine in the brain and the albumen gland. No significant difference in dopamine quantity was found when the brain and the albumen gland of randomly mating, virgin and first time mated snails were compared.
        
        
          Conclusions
          Our results represent the first detailed studies regarding the catecholamine innervation and quantitation of neurotransmitters in the albumen gland. In this study we localized catecholaminergic neurons and axons in the albumen gland and the brain, identified these neurons and axons as dopaminergic, reported monoamines present in the albumen gland and the brain, and compared the dopamine content in the brain and the albumen gland of randomly mating, virgin and first time mated snails.
2011 CMHS Uniform Reporting System (URS) Output Tables for North Dakota

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 527495: 3-Hydroxyamitriptyline

Chemical compound data from PubChem database. IUPAC Name: 2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaen-5-ol. Molecular Formula: C20H23NO. Molecular Weight: 293.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.